Search for content, post, videos

Profits for Novo Nordisk in 2014

Novo Nordisk increased operating profit in local currencies by 13 percent and by 10 percent in Danish kroner to DKK 34.5 billion in 2014. Sales growth of 8 percent in local currencies was driven by increased sales of Levemir® and Victoza®.    Sales also increased by 6 percent in Danish kron
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.